Evolution AB (publ) (LON:0RQ6)
663.85
-59.64 (-8.24%)
At close: Oct 23, 2025
Evolution AB Revenue
Evolution AB had revenue of 507.12M EUR in the quarter ending September 30, 2025, a decrease of -2.36%. This brings the company's revenue in the last twelve months to 2.24B, up 11.61% year-over-year. In the year 2024, Evolution AB had annual revenue of 2.21B with 23.10% growth.
Revenue (ttm)
2.24B EUR
Revenue Growth
+11.61%
P/S Ratio
5.55
Revenue / Employee
103.23K EUR
Employees
21,673
Market Cap
10.83B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.21B | 415.54M | 23.10% |
| Dec 31, 2023 | 1.80B | 341.86M | 23.47% |
| Dec 31, 2022 | 1.46B | 387.96M | 36.30% |
| Dec 31, 2021 | 1.07B | 507.64M | 90.47% |
| Dec 31, 2020 | 561.13M | 195.38M | 53.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |